The effects of a diet based on Iranian medicine on COVID-19 patients

Phase 3

• Conditions: new Corona virus disease 2019.; new Corona virus disease 2019; U07.1

• Registration Number: IRCT20220227054140N1
• Lead Sponsor: Artesh University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Patients who have positive PCR for COVID-19
Patients with COVID-19 who have been admitted to hospital

Exclusion Criteria

Patients who are pregnant or breastfeeding
Patients with underlying diseases such as: diabetes, hypertension and cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ICU admission or intubation. Timepoint: During hospitalization, daily. Method of measurement: Evaluator report.

Secondary Outcome Measures

Name	Time	Method
Clinical symptoms (cough intensity, The degree of shortness of breath). Timepoint: During hospitalization, daily. Method of measurement: Symptoms by asking the patient as a scale indicator and signs by monitoring the patient by the assessor.;Inflammatory markers (ESR, CRP, LDH, WBC). Timepoint: before and after the 5 days intervention. Method of measurement: Quantitative laboratory measurements of blood samples.;Clinical examinations (RR, SO2). Timepoint: During hospitalization, daily. Method of measurement: Through clinical examination and use of pulse oximeter.